FARYDAK: payments to doctors
Payments that named FARYDAK as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $723K
- Providers
- 1,084
- Transactions
- 3,370
- Average per transaction
- $214
The per-transaction average — $214 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,084 providers the average total is $667, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Secura Bio, Inc. | $677,740 | 93.8% |
| Novartis | $44,782 | 6.2% |